Risk of thrombosis with the use of sirolimus-eluting stents for percutaneous coronary intervention (from registry and clinical trial data)

Anthony A. Bavry, Dharam J. Kumbhani, Thomas J. Helton, Deepak L. Bhatt

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

We conducted a meta-analysis on 6 studies in 2,963 patients who had coronary artery disease and received a sirolimus-eluting stent or a bare metal stent for revascularization. Compared with bare metal stents, sirolimus-eluting stents did not appear to increase the risk for thrombosis up to 13.5 months after coronary intervention (risk ratio 0.49, 95% confidence interval 0.22 to 1.12, p = 0.09).

Original languageEnglish (US)
Pages (from-to)1469-1472
Number of pages4
JournalAmerican Journal of Cardiology
Volume95
Issue number12
DOIs
StatePublished - Jun 15 2005

Fingerprint

Sirolimus
Percutaneous Coronary Intervention
Stents
Registries
Thrombosis
Clinical Trials
Metals
Meta-Analysis
Coronary Artery Disease
Odds Ratio
Confidence Intervals

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Risk of thrombosis with the use of sirolimus-eluting stents for percutaneous coronary intervention (from registry and clinical trial data). / Bavry, Anthony A.; Kumbhani, Dharam J.; Helton, Thomas J.; Bhatt, Deepak L.

In: American Journal of Cardiology, Vol. 95, No. 12, 15.06.2005, p. 1469-1472.

Research output: Contribution to journalArticle

@article{28804c833bab454988379c7c1d7884e7,
title = "Risk of thrombosis with the use of sirolimus-eluting stents for percutaneous coronary intervention (from registry and clinical trial data)",
abstract = "We conducted a meta-analysis on 6 studies in 2,963 patients who had coronary artery disease and received a sirolimus-eluting stent or a bare metal stent for revascularization. Compared with bare metal stents, sirolimus-eluting stents did not appear to increase the risk for thrombosis up to 13.5 months after coronary intervention (risk ratio 0.49, 95{\%} confidence interval 0.22 to 1.12, p = 0.09).",
author = "Bavry, {Anthony A.} and Kumbhani, {Dharam J.} and Helton, {Thomas J.} and Bhatt, {Deepak L.}",
year = "2005",
month = "6",
day = "15",
doi = "10.1016/j.amjcard.2005.02.015",
language = "English (US)",
volume = "95",
pages = "1469--1472",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "12",

}

TY - JOUR

T1 - Risk of thrombosis with the use of sirolimus-eluting stents for percutaneous coronary intervention (from registry and clinical trial data)

AU - Bavry, Anthony A.

AU - Kumbhani, Dharam J.

AU - Helton, Thomas J.

AU - Bhatt, Deepak L.

PY - 2005/6/15

Y1 - 2005/6/15

N2 - We conducted a meta-analysis on 6 studies in 2,963 patients who had coronary artery disease and received a sirolimus-eluting stent or a bare metal stent for revascularization. Compared with bare metal stents, sirolimus-eluting stents did not appear to increase the risk for thrombosis up to 13.5 months after coronary intervention (risk ratio 0.49, 95% confidence interval 0.22 to 1.12, p = 0.09).

AB - We conducted a meta-analysis on 6 studies in 2,963 patients who had coronary artery disease and received a sirolimus-eluting stent or a bare metal stent for revascularization. Compared with bare metal stents, sirolimus-eluting stents did not appear to increase the risk for thrombosis up to 13.5 months after coronary intervention (risk ratio 0.49, 95% confidence interval 0.22 to 1.12, p = 0.09).

UR - http://www.scopus.com/inward/record.url?scp=20444478565&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20444478565&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2005.02.015

DO - 10.1016/j.amjcard.2005.02.015

M3 - Article

C2 - 15950574

AN - SCOPUS:20444478565

VL - 95

SP - 1469

EP - 1472

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 12

ER -